Mehul Patel, MD
Urology · Atlanta, GANPI 1457747024
Payments from drug & device makers
Across 125 payments — averaging $64.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Coloplast$2K
- Endo Pharmaceuticals Inc.$919
- Acerus Pharmaceuticals Corporation$280
- Medtronic$185
- Endo USA, Inc.$174
- plus $852 from 21 others
What the payments were for
- Travel & lodging$2,59732%
- Food & beverage$5,42367%
- Education$911%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 49 | $3,564 |
| Coloplast | 13 | $2,137 |
| Endo Pharmaceuticals Inc. | 15 | $919 |
| Acerus Pharmaceuticals Corporation | 3 | $280 |
| Medtronic | 2 | $185 |
| Endo USA, Inc. | 7 | $174 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $118 |
| Sumitomo Pharma America, Inc. | 5 | $106 |
| Teleflex LLC | 3 | $101 |
| Blue Earth Diagnostics | 4 | $94 |
| Myriad Genetic Laboratories, Inc. | 2 | $53 |
| Procept Biorobotics Corporation | 2 | $40 |
| Profound Medical Corp. | 2 | $31 |
| Olympus America Inc. | 2 | $31 |
| Mission Pharmacal Company | 1 | $29 |
| Astellas Pharma US Inc | 1 | $29 |
| Urovant Sciences Inc | 1 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Tempus AI, Inc | 1 | $24 |
| 180 Medical, Inc. | 1 | $22 |
| Calyxo, Inc. | 1 | $22 |
| KARL Storz Endoscopy-america | 1 | $19 |
| Immunitybio, Inc. | 1 | $18 |
| AbbVie | 1 | $18 |
| Tolmar, Inc. | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| EDAP Technomed Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN$1,844
- AdVance XP$1,362
- XIAFLEX$541
- GENERAL ERECTILE DYSFUNCTION$506
- AMS 700 CXR RTE KIT$387
- Porges Coloplast$186
- TACTRA$132
- INTERSTIM$131
- Natesto$124
- AMS$112
How this compares
$8,111 in reported general payments places this provider in the 70th percentile of 369 urology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 224 | $3,139 |
| Estradiol | 20 | $1,167 |
| Silodosin | 12 | $1,059 |
| Finasteride | 65 | $947 |
| Cefdinir | 22 | $319 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 15 | $286 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 28 | $200 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 29 | $160 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 35 | $123 |
| Levofloxacin | 28 | $101 |
Paid to pharmacies, not to this prescriber.
Other urology in Atlanta
- Viraj MasterAtlanta$2M
- Vikram NarayanAtlanta$1.1M
- Kenneth OganAtlanta$425K
- Tariq HakkyAtlanta$140K
- Shreyas JoshiAtlanta$98K
- James BennettAtlanta$93K
- Anthony BarnesAtlanta$89K
- Matthew SandAtlanta$77K
- Brendan BrowneAtlanta$53K
- John PattarasAtlanta$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.